The effect of melatonin administration on pituitary hormone secretion in man - PubMed (original) (raw)
Clinical Trial
The effect of melatonin administration on pituitary hormone secretion in man
M L Forsling et al. Clin Endocrinol (Oxf). 1999 Nov.
Abstract
Objective: Evidence is accumulating that the nocturnal increase in melatonin may influence pituitary hormone secretion. The aim of this study was to determine the effect of exogenous melatonin, in concencetrations spanning the physiological range, on the release of pituitary hormones in man during daylight hours.
Design: A double blind, randomized, crossover study.
Subjects: Eight healthy male volunteers with a mean age of 21 +/- 0.5 years were studied on four occasions, observations being made after the adminstration of melatonin in doses of 0.05, 0.5 or 5.0 mg or placebo. They refrained from taking heavy exercise, alcohol and from smoking for 24 h prior to the study.
Measurements: Serum cortisol, growth hormone, prolactin and plasma oxytocin, vasopressin, sodium, osmolality and packed cell volume were measured in samples taken at 30 minutes intervals for 150 minutes after the administration of melatonin.
Results: Melatonin produced dose-dependent changes in circulating concentrations of oxytocin and vasopressin, the 0.5 mg dose being stimulatory, while 5.0 mg was inhibitory. These two doses stimulated growth hormone release, while there was no significant effect on prolactin or cortisol release.
Conclusions: These results confirm that the nocturnal increase in melatonin could contribute to the patterns of oxytocin, vasopressin and growth hormone release seen over 24 h.
Similar articles
- Melatonin administration and pituitary hormone secretion.
Kostoglou-Athanassiou I, Treacher DF, Wheeler MJ, Forsling ML. Kostoglou-Athanassiou I, et al. Clin Endocrinol (Oxf). 1998 Jan;48(1):31-7. doi: 10.1046/j.1365-2265.1998.00341.x. Clin Endocrinol (Oxf). 1998. PMID: 9509065 Clinical Trial. - Bright light exposure and pituitary hormone secretion.
Kostoglou-Athanassiou I, Treacher DF, Wheeler MJ, Forsling ML. Kostoglou-Athanassiou I, et al. Clin Endocrinol (Oxf). 1998 Jan;48(1):73-9. doi: 10.1046/j.1365-2265.1998.00355.x. Clin Endocrinol (Oxf). 1998. PMID: 9509071 Clinical Trial. - The effect of exogenous melatonin on stimulated neurohypophysial hormone release in man.
Forsling ML, Williams AJ. Forsling ML, et al. Clin Endocrinol (Oxf). 2002 Nov;57(5):615-20. doi: 10.1046/j.1365-2265.2002.01644.x. Clin Endocrinol (Oxf). 2002. PMID: 12390335 Clinical Trial. - Diurnal rhythms in neurohypophysial function.
Forsling ML. Forsling ML. Exp Physiol. 2000 Mar;85 Spec No:179S-186S. doi: 10.1111/j.1469-445x.2000.tb00022.x. Exp Physiol. 2000. PMID: 10795921 Review. - [Measurements of serum pituitary hormones and dynamic tests to evaluate the pituitary functions].
Nakai T, Nomura F, Takekoshi K. Nakai T, et al. Nihon Rinsho. 1993 Oct;51(10):2665-72. Nihon Rinsho. 1993. PMID: 8254937 Review. Japanese.
Cited by
- Melatonin's actions are not limited to sleep.
Venaki E, Koukkou E, Ilias I. Venaki E, et al. World J Exp Med. 2023 Mar 14;13(2):4-6. doi: 10.5493/wjem.v13.i2.4. eCollection 2023 Mar 14. World J Exp Med. 2023. PMID: 36970311 Free PMC article. - Role of Melatonin, Galanin, and RFamide Neuropeptides QRFP26 and QRFP43 in the Neuroendocrine Control of Pancreatic β-Cell Function.
Gesmundo I, Villanova T, Banfi D, Gamba G, Granata R. Gesmundo I, et al. Front Endocrinol (Lausanne). 2017 Jul 3;8:143. doi: 10.3389/fendo.2017.00143. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28729853 Free PMC article. Review. - Melatonin does not attenuate dynamic cardiovascular and cerebrovascular reflex responses to acute hypotension in healthy men.
Bang J, Park YS, Jeong SM, Song JG, Kim YK, Hwang GS. Bang J, et al. Korean J Anesthesiol. 2012 Sep;63(3):245-52. doi: 10.4097/kjae.2012.63.3.245. Epub 2012 Sep 14. Korean J Anesthesiol. 2012. PMID: 23060982 Free PMC article. - Melatonin improves memory acquisition under stress independent of stress hormone release.
Rimmele U, Spillmann M, Bärtschi C, Wolf OT, Weber CS, Ehlert U, Wirtz PH. Rimmele U, et al. Psychopharmacology (Berl). 2009 Mar;202(4):663-72. doi: 10.1007/s00213-008-1344-z. Epub 2008 Oct 14. Psychopharmacology (Berl). 2009. PMID: 18853147 Clinical Trial. - Melatonin's role in managing nocturia in Parkinson disease: A critical examination of recent studies.
Lin YH, Juang HH. Lin YH, et al. Eur J Neurol. 2024 May;31(5):e16220. doi: 10.1111/ene.16220. Epub 2024 Jan 18. Eur J Neurol. 2024. PMID: 38239076 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources